NM_002878.4(RAD51D):c.355T>C (p.Cys119Arg) AND Hereditary breast ovarian cancer syndrome
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Apr 9, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000709444.5
Allele description [Variation Report for NM_002878.4(RAD51D):c.355T>C (p.Cys119Arg)]
NM_002878.4(RAD51D):c.355T>C (p.Cys119Arg)
Condition(s)
- Name:
- Hereditary breast ovarian cancer syndrome
- Synonyms:
- Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145
-
doublecortin domain-containing protein 2 isoform X3 [Mus musculus]
doublecortin domain-containing protein 2 isoform X3 [Mus musculus]gi|1907093009|ref|XP_036013818.1|Protein
-
PREDICTED: Oncorhynchus kisutch U8 snoRNA-decapping enzyme (LOC109870870), trans...
PREDICTED: Oncorhynchus kisutch U8 snoRNA-decapping enzyme (LOC109870870), transcript variant X5, mRNAgi|1782364971|ref|XM_020461551.2|Nucleotide
-
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcr...
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcript variant X24, mRNAgi|2217302677|ref|XM_047433072.1|Nucleotide
-
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcr...
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcript variant X11, mRNAgi|2217302654|ref|XM_011522039.3|Nucleotide
-
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcr...
PREDICTED: Homo sapiens pseudopodium enriched atypical kinase 1 (PEAK1), transcript variant X30, mRNAgi|2462545956|ref|XM_054378842.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024